Bliss Gvs Pharma Ltd vs Marksans Pharma Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 13, 2026

Key Highlights

The Latest Trading Price of Bliss GVS Pharma Ltd is ₹ 279.95 as of 13 May 15:30 . The P/E Ratio of Bliss GVS Pharma Ltd changed from 14.9 on March 2021 to 14.7 on March 2025 . This represents a CAGR of -0.27% over 5 yearsThe P/E Ratio of Marksans Pharma Ltd changed from 8.7 on March 2021 to 26.5 on March 2025 . This represents a CAGR of 24.95% over 5 years The Market Cap of Bliss GVS Pharma Ltd changed from ₹ 1018 crore on March 2021 to ₹ 1238 crore on March 2025 . This represents a CAGR of 4.00% over 5 yearsThe Market Cap of Marksans Pharma Ltd changed from ₹ 2044 crore on March 2021 to ₹ 10076 crore on March 2025 . This represents a CAGR of 37.58% over 5 years The revenue of Bliss GVS Pharma Ltd for the Mar '26 is ₹ 268.18 crore as compare to the Dec '25 revenue of ₹ 236.71 crore. This represent the growth of 13.29% The revenue of Marksans Pharma Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 774.57 crore. This represent the decline of -100% The ebitda of Bliss GVS Pharma Ltd for the Mar '26 is ₹ 55.63 crore as compare to the Dec '25 ebitda of ₹ 50.73 crore. This represent the growth of 9.66% The ebitda of Marksans Pharma Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ 180.89 crore. This represent the decline of -100% The net profit of Bliss GVS Pharma Ltd changed from ₹ 22.11 crore to ₹ 37 crore over 8 quarters. This represents a CAGR of 29.36% The net profit of Marksans Pharma Ltd changed from ₹ 89.07 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of -100.00% The Dividend Payout of Bliss GVS Pharma Ltd changed from 7.64 % on March 2021 to 7.64 % on March 2025 . This represents a CAGR of 0.00% over 5 yearsThe Dividend Payout of Marksans Pharma Ltd changed from 10.4 % on March 2021 to 19.26 % on March 2025 . This represents a CAGR of 13.12% over 5 years .

About Bliss GVS Pharma Ltd

Bliss GVS Pharma Limited was originally incorporated as a Private Limited Company in the name of Bliss Chemicals & Pharmaceuticals India Private Limited in 1984.
The status converted into a Public Limited Company and the name of the Company was changed to Bliss Chemicals & Pharmaceuticals India Limited and further to Bliss GVS Pharma Limited on May 12, 2006. The Company is engaged in manufacturing, marketing, trading and export of pharmaceutical products.
The Company has its manufacturing facility at Palghar which is WHO GMP approved.
The business operates five cutting-edge production facilities that adhere to WHO-GMP, EU-MP, ISO 14001 and OHSAS 45001 standards. The company commenced its business in 1985.
In 1994 the company introduced a new pharmaceutical product VAGID. During the financial year ended 31 March 2014, Bliss GVS Pharma's R&D center, received approval from Government of India's Department for Scientific & Industrial Research (DSIR).

About Marksans Pharma Ltd

Marksans Pharma Limited was formerly incorporated as 'Tasc Pharmaceuticals Limited' in April, 1982.
Pursuant to the Scheme of Amalgamation, name of the Company was changed from Tasc Pharmaceuticals Limited to Marksans Pharma Limited from 10th October, 2005.
The Company primarily engaged in the business of research, manufacture, marketing and sale of pharmaceutical formulation.
The Company's research and development facilities are located in Verna, Goa and R & D center in Navi Mumbai. In 2004-05, the Company amalgamated with M/s.
Marksans Pharma Limited (formerly M/s.

FAQs for the comparison of Bliss GVS Pharma Ltd and Marksans Pharma Ltd

Which company has a larger market capitalization, Bliss GVS Pharma Ltd or Marksans Pharma Ltd?

Market cap of Bliss GVS Pharma Ltd is 2,961 Cr while Market cap of Marksans Pharma Ltd is 9,072 Cr

What are the key factors driving the stock performance of Bliss GVS Pharma Ltd and Marksans Pharma Ltd?

The stock performance of Bliss GVS Pharma Ltd and Marksans Pharma Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Bliss GVS Pharma Ltd and Marksans Pharma Ltd?

As of May 13, 2026, the Bliss GVS Pharma Ltd stock price is INR ₹279.95. On the other hand, Marksans Pharma Ltd stock price is INR ₹200.2.

How do dividend payouts of Bliss GVS Pharma Ltd and Marksans Pharma Ltd compare?

To compare the dividend payouts of Bliss GVS Pharma Ltd and Marksans Pharma Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.